Jay Chauhan, PharmD

Title: Medical Science Liaison

Organization: NS Pharma

Bio: Jay Chauhan is a Medical Science Liaison (MSL) at NS Pharma, responsible for engaging with neuromuscular specialists to advance the treatment landscape for Duchenne Muscular Dystrophy (DMD). Joining NS Pharma in 2021, Dr. Chauhan utilizes his Doctor of Pharmacy (PharmD) education to communicate scientific information from a medical perspective and is passionate in collaborating with the DMD community to provide an opportunity for patients to overcome their rare disease.

Exon Skipping and Read Through Agents Panel

A brief introduction on the rationale behind mechanisms of endogenous dystrophin restoration, like exon skipping and read through agent therapies, followed by critical information and updates from the companies in this space. Moderated discussion included.

Barry Byrne, MD, PhD

Professor and Associate Chair

University of Florida, Department of Pediatrics

Jay Chauhan, PharmD

Medical Science Liaison

NS Pharma

Brett Crawford, PhD

Executive Director and Head of the Musculoskeletal Therapeutic Area

BioMarin Pharmaceutical Inc.

Ash Dugar, PhD

Senior Vice President, Medical Affairs

Dyne Therapeutics

Xiao Shelley Hu, PhD, MS


Wave Life Sciences

Matthew Klein, M.D., M.S., FACS

Chief Operating Officer

PTC Therapeutics

Nerissa Kreher, MD, MBA

Chief Medical Officer

Entrada Therapeutics

James McArthur, PhD

President and Chief Executive Officer


Mark Stahl, MD, PhD

Senior Medical Director, Clinical Development

Avidity Biosciences

Deanna Tucker, PharmD

Senior Medical Science Liaison

Sarepta Therapeutics